PagerDuty (PD) 10-Q 3 Sep 21 2022 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jul. 31, 2021	Sep. 01, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2021
Document Transition Report	false
Entity File Number	001-38856
Entity Registrant Name	PAGERDUTY, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-2793871
Entity Address, Address Line One	600 Townsend St.
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94103
City Area Code	844
Local Phone Number	800-3889
Title of 12(b) Security	Common Stock, $0.000005 par value
Trading Symbol	PD
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		84,972,465
Entity Central Index Key	0001568100
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Current assets:
Cash and cash equivalents	$ 354,525	$ 339,166
Investments	192,296	221,112
Accounts receivable, net of allowance for doubtful accounts of $1,008 and $1,188 as of July 31, 2021 and January 31, 2021, respectively	48,148	55,119
Deferred contract costs, current	13,826	12,330
Prepaid expenses and other current assets	14,987	10,587
Total current assets	623,782	638,314
Property and equipment, net	14,116	12,639
Deferred contract costs, non-current	20,434	19,257
Lease right-of-use assets	22,482	24,691
Goodwill	72,126	72,126
Intangible assets, net	24,883	26,633
Other assets	689	1,783
Total assets	778,512	795,443
Current liabilities:
Accounts payable	6,949	5,747
Accrued expenses and other current liabilities	14,101	9,627
Accrued compensation	24,542	28,372
Deferred revenue, current	128,145	123,686
Lease liabilities, current	5,469	5,262
Total current liabilities	179,206	172,694
Convertible senior notes, net	280,162	217,528
Deferred revenue, non-current	5,857	6,286
Lease liabilities, non-current	23,831	26,542
Other liabilities	4,284	5,666
Total liabilities	493,340	428,716
Commitments and contingencies (Note 10)
Stockholders’ equity:
Common stock	0	0
Additional paid-in capital	578,728	614,494
Accumulated other comprehensive income	31	343
Accumulated deficit	(293,587)	(248,110)
Total stockholders’ equity	285,172	366,727
Total liabilities and stockholders’ equity	$ 778,512	$ 795,443

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Current assets:
Allowance for doubtful accounts	$ 1,008	$ 1,188

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Income Statement And Statement Of Comprehensive Income [Abstract]
Revenue	$ 67,536	$ 50,714	$ 131,127	$ 100,500
Cost of revenue	11,976	6,637	22,394	13,600
Gross profit	55,560	44,077	108,733	86,900
Operating expenses:
Research and development	22,909	15,535	43,508	30,549
Sales and marketing	40,814	27,511	78,048	54,247
General and administrative	20,294	14,480	36,872	28,153
Total operating expenses	84,017	57,526	158,428	112,949
Loss from operations	(28,457)	(13,449)	(49,695)	(26,049)
Interest income	783	1,048	1,601	2,401
Interest expense	(1,378)	(1,608)	(2,695)	(1,608)
Other expense, net	(586)	(431)	(1,202)	(412)
Loss before provision for income taxes	(29,638)	(14,440)	(51,991)	(25,668)
Provision for income taxes	(23)	(248)	(228)	(479)
Net loss	(29,661)	(14,688)	(52,219)	(26,147)
Other comprehensive (loss) income:
Unrealized (loss) gain on investments	(108)	277	(312)	919
Total comprehensive loss	$ (29,769)	$ (14,411)	$ (52,531)	$ (25,228)
Net loss per share, basic (in dollars per share)	$ (0.35)	$ (0.19)	$ (0.63)	$ (0.33)
Net loss per share, diluted (in dollars per share)	$ (0.35)	$ (0.19)	$ (0.63)	$ (0.33)
Weighted average shares used in calculating net loss per share, basic (in shares)	83,895	78,775	83,413	78,278
Weighted average shares used in calculating net loss per share, diluted (in shares)	83,895	78,775	83,413	78,278

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in CapitalCumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Accumulated DeficitCumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jan. 31, 2020			77,793,540
Beginning balance at Jan. 31, 2020	$ 307,938		$ 0	$ 487,008		$ 137	$ (179,207)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases (in shares)			1,286,892
Issuance of common stock upon exercise of stock options and restricted stock agreements	5,771			5,771
Vesting of restricted stock units, net of employee payroll taxes (in shares)			93,942
Vesting of restricted stock units, net of employee payroll taxes	(1,743)			(1,743)
Vesting of early exercised options	507			507
Equity component of convertible senior notes, net of issuance costs	68,478			68,478
Purchases of capped calls related to convertible senior notes	(35,708)			(35,708)
Issuance of common stock in connection with employee stock purchase plan (in shares)			181,253
Issuance of common stock in connection with employee stock purchase plan	3,558			3,558
Other comprehensive income (loss)	919					919
Stock-based compensation	18,298			18,298
Net loss	(26,147)						(26,147)
Ending balance (in shares) at Jul. 31, 2020			79,355,627
Ending balance at Jul. 31, 2020	341,871		$ 0	546,169		1,056	(205,354)
Beginning balance (in shares) at Apr. 30, 2020			78,526,004
Beginning balance at Apr. 30, 2020	307,543		$ 0	497,430		779	(190,666)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases (in shares)			557,467
Issuance of common stock upon exercise of stock options and restricted stock agreements	3,927			3,927
Vesting of restricted stock units, net of employee payroll taxes (in shares)			90,903
Vesting of restricted stock units, net of employee payroll taxes	(1,697)			(1,697)
Vesting of early exercised options	191			191
Equity component of convertible senior notes, net of issuance costs	68,478			68,478
Purchases of capped calls related to convertible senior notes	(35,708)			(35,708)
Issuance of common stock in connection with employee stock purchase plan (in shares)			181,253
Issuance of common stock in connection with employee stock purchase plan	3,558			3,558
Other comprehensive income (loss)	277					277
Stock-based compensation	9,990			9,990
Net loss	(14,688)						(14,688)
Ending balance (in shares) at Jul. 31, 2020			79,355,627
Ending balance at Jul. 31, 2020	341,871		$ 0	546,169		1,056	(205,354)
Beginning balance (in shares) at Jan. 31, 2021			82,882,424
Beginning balance at Jan. 31, 2021	366,727	$ (61,736)	$ 0	614,494	$ (68,478)	343	(248,110)	$ 6,742
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases (in shares)			1,286,266
Issuance of common stock upon exercise of stock options and restricted stock agreements	8,222			8,222
Vesting of restricted stock units, net of employee payroll taxes (in shares)			407,887
Vesting of restricted stock units, net of employee payroll taxes	(11,003)			(11,003)
Shares issued related to a business combination (in shares)			2,073
Issuance of common stock in connection with employee stock purchase plan (in shares)			222,474
Issuance of common stock in connection with employee stock purchase plan	4,889			4,889
Other comprehensive income (loss)	(312)					(312)
Stock-based compensation	30,604			30,604
Net loss	(52,219)						(52,219)
Ending balance (in shares) at Jul. 31, 2021			84,801,124
Ending balance at Jul. 31, 2021	285,172		$ 0	578,728		31	(293,587)
Beginning balance (in shares) at Apr. 30, 2021			83,595,225
Beginning balance at Apr. 30, 2021	294,056		$ 0	557,843		139	(263,926)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases (in shares)			749,673
Issuance of common stock upon exercise of stock options and restricted stock agreements	5,379			5,379
Vesting of restricted stock units, net of employee payroll taxes (in shares)			233,752
Vesting of restricted stock units, net of employee payroll taxes	(6,073)			(6,073)
Issuance of common stock in connection with employee stock purchase plan (in shares)			222,474
Issuance of common stock in connection with employee stock purchase plan	4,889			4,889
Other comprehensive income (loss)	(108)					(108)
Stock-based compensation	16,690			16,690
Net loss	(29,661)						(29,661)
Ending balance (in shares) at Jul. 31, 2021			84,801,124
Ending balance at Jul. 31, 2021	$ 285,172		$ 0	$ 578,728		$ 31	$ (293,587)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)	6 Months Ended
	Jul. 31, 2021
Statement of Stockholders' Equity [Abstract]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands		6 Months Ended
		Jul. 31, 2021	Jul. 31, 2020
Cash flows from operating activities
Net loss		$ (52,219)	$ (26,147)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization		4,027	2,039
Amortization of deferred contract costs		6,812	5,064
Amortization of debt discount and issuance costs	[1]	898	1,258
Stock-based compensation		30,088	18,276
Non-cash lease expense		2,209	2,204
Other		1,695	1,426
Changes in operating assets and liabilities:
Accounts receivable		6,473	(1,293)
Deferred contract costs		(9,485)	(6,199)
Prepaid expenses and other assets		(2,762)	(4,989)
Accounts payable		1,179	(1,549)
Accrued expenses and other liabilities		3,373	3,618
Accrued compensation		(3,830)	1,287
Deferred revenue		4,030	8,611
Lease liabilities		(2,504)	(1,744)
Net cash (used in) provided by operating activities		(10,016)	1,862
Cash flows from investing activities
Purchases of property and equipment		(1,291)	(3,292)
Capitalization of internal-use software costs		(1,917)	(111)
Payments related to a business acquisition		(160)	0
Proceeds from maturities of held-to-maturity investments		0	24,040
Purchases of available-for-sale investments		(116,103)	(100,029)
Proceeds from maturities of available-for-sale investments		116,150	71,632
Proceeds from sales of available-for-sale investments		27,380	7,285
Net cash provided by (used in) investing activities		24,059	(475)
Cash flows from financing activities
Proceeds from issuance of convertible senior notes, net of issuance costs paid of $8,151		0	279,349
Purchases of capped calls related to convertible senior notes		0	(35,708)
Proceeds from employee stock purchase plan		4,889	3,558
Proceeds from issuance of common stock upon exercise of stock options		7,430	5,771
Employee payroll taxes paid related to net share settlement of restricted stock units		(11,003)	(1,743)
Net cash provided by financing activities		1,316	251,227
Net increase in cash, cash equivalents, and restricted cash		15,359	252,614
Cash, cash equivalents, and restricted cash at beginning of period		339,166	124,024
Cash, cash equivalents, and restricted cash at end of period		354,525	376,638
Supplemental cash flow data:
Cash paid for income taxes		72	0
Cash paid for interest		1,797	0
Non-cash investing and financing activities:
Vesting of early exercised options		0	507
Purchase of property and equipment, accrued but not yet paid		402	385
Costs related to issuance of convertible senior notes, accrued but not yet paid		0	1,154
Stock-based compensation capitalized in internal use software		516	0
Receivables for cash in-transit on stock option exercises		$ 792	$ 0
[1]	During the first quarter of fiscal 2022, the Company early adopted ASU 2020-06 which resulted in the elimination of amortization of debt discount on our 1.25% Convertible Senior Notes (the “Notes”) from February 1, 2021.

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Parenthetical) $ in Thousands	6 Months Ended
	Jul. 31, 2020USD ($)
Issuance of convertible senior notes, issuance costs paid	$ 8,151

Description of Business and Bas

Description of Business and Basis of Presentation	6 Months Ended
	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	Description of Business and Basis of Presentation Description of Business PagerDuty, Inc. was incorporated under the laws of the state of Delaware in May 2010. PagerDuty acts as the central nervous system for the digital enterprise. PagerDuty harnesses digital signals from virtually any software-enabled system or device, combines it with human response data and orchestrates teams to take the right actions in real time. The Company’s products help organizations improve operations, accelerate innovation, increase revenue, mitigate security risk, and deliver a great customer experience. As used herein, “PagerDuty”, “we”, “our”, “the Company” and similar terms include PagerDuty, Inc., unless the context indicates otherwise. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet as of January 31, 2021 was derived from the audited consolidated financial statements as of that date but does not include all of the information and notes required by GAAP for complete financial statements. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended January 31, 2021, included in the Company’s Annual Report on Form 10-K, filed with the SEC. The condensed consolidated financial statements include the results of PagerDuty, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of management, the information contained herein reflects all adjustments necessary for a fair presentation of the Company’s results of operations, financial position, cash flows, and statements of stockholders’ equity. The results of operations for the three and six months ended July 31, 2021 are not necessarily indicative of the results to be expected for the full year ending January 31, 2022 or for any other interim period, or for any future year. The Company’s fiscal year ends on January 31. References to fiscal 2022, for example, refer to the fiscal year ending January 31, 2022. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make, on an ongoing basis, estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The Company’s most significant estimates and judgments involve the fair value of stock awards, period of benefit for amortizing deferred contract costs, the determination of the allowance for doubtful accounts, the provision for income taxes, including the related valuation allowance and any uncertain tax positions, fair value of acquired assets and assumed liabilities, impairment of goodwill and intangible assets, the incremental borrowing rate for lease liabilities, and estimates related to our revenue recognition, such as the assessment of performance obligations in our revenue arrangements and the fair value assigned to each performance obligation, among others. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. In December 2019, the novel coronavirus and resulting disease (“COVID-19”) was reported and in March 2020 the World Health Organization declared it a pandemic. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the condensed consolidated financial statements during the three and six months ended July 31, 2021 and 2020. As events continue to evolve and additional information becomes available, our assumptions and estimates may change materially in future periods.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Concentrations of Risk and Significant Customers The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, available-for-sale investments, and accounts receivable. All of the Company’s cash and cash equivalents and investments are invested in money market funds, United States (“U.S.”) Treasury securities, commercial paper, corporate debt securities, or U.S. Government agency securities that management believes to be of high credit quality. No single customer accounted for 10% of the total accounts receivable balance as of July 31, 2021 or January 31, 2021. No single customer represented 10% or more of revenue for the three and six months ended July 31, 2021 or 2020. Segment Information The Company manages its operations and allocates resources as one operating segment. The Company’s chief operating decision maker (“CODM”) is its chief executive officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources. Refer to Note 15, “Geographic Information” for information regarding the Company's long-lived assets and revenue by geography. Related Party Transactions Certain members of the Company’s Board of Directors serve as directors of, or are executive officers of, and in some cases are investors in, companies that are customers or vendors of the Company. The Company billed $1.1 million to entities associated with related parties during the three and six months ended July 31, 2021, which were included in the accounts receivable balance as of July 31, 2021. Other related party transactions were not material for the three and six months ended July 31, 2021 and 2020. Significant Accounting Policies There have been no significant changes to our significant accounting policies as compared to those described in our Annual Report on Form 10-K for the fiscal year ended January 31, 2021, other than as set forth below. Stock-Based Compensation The Company recognizes compensation expense for all stock-based payment awards, including stock options, restricted stock units (“RSUs”), and performance stock units (“PSUs”), based on the estimated fair value of the award on the grant date. The Company estimates the fair value of stock options issued to employees on the date of grant using the Black-Scholes option pricing model, which is impacted by the estimated fair value of the Company’s common stock, as well as certain assumptions including the expected volatility over the term of the option awards, the expected term of the awards, risk-free interest rates and the expected dividend yield. Assumptions and estimates used in the determination of the fair value of stock options are as follows: Expected volatility —Expected volatility is a measure of the amount by which the stock price is expected to fluctuate. Since the Company does not have sufficient trading history for its common stock, it estimates the expected volatility of its stock options by taking the average historical volatility of a group of comparable publicly traded companies over a period equal to the expected life of the options. Expected term —The Company determines the expected term based on the average period the stock options are expected to remain outstanding, generally calculated as the midpoint of the stock options’ vesting term and contractual expiration period, as the Company does not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. Risk-free rate —The Company uses the U.S. Treasury yield for its risk-free interest rate that corresponds with the expected term. Expected dividend yield —The Company utilizes a dividend yield of zero, as it does not currently issue dividends and does not expect to in the future. The Company estimates the fair value of RSUs and PSUs at our stock price on the grant date. The Company estimates the fair value of shares to be issued under the employee stock purchase plan (the “ESPP”) on the first day of the offering period using the Black-Scholes valuation model, which is impacted by the estimated fair value of the Company’s common stock, as well as certain assumptions including the expected volatility over the term of the offering period, the expected term of the awards, risk-free interest rates and the expected dividend yield. Assumptions used in the determination of the fair value of the ESPP are the same as those used in the determination of the fair value of our stock options. The Company generally recognizes compensation expense for employee stock-based payment awards on a straight-line basis over the period during which an award recipient is required to provide services in exchange for the award (generally the vesting period of the award), with the exception of PSUs which are recognized using the accelerated attribution method. The Company accounts for forfeitures as they occur. The fair value of each non-employee stock option is estimated at the date of grant using the Black-Scholes option pricing model and is not remeasured over the vesting term. Assumptions used in valuing non-employee stock options are generally consistent with those used for employee stock options with the exception that the expected term is over the contractual life. Recently Adopted Accounting Pronouncements In August 2020, the FASB issued Accounting Standard Update No. 2020-06, Debt—Debt with Conversion Options (“Subtopic 470-20”) and Derivatives and Hedging—Contracts in Entity’s Own Equity (“Subtopic 815-40”) (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity's own equity. ASU 2020-06 also improves and amends the related Earnings Per Share guidance for both Subtopics. The ASU is part of the FASB's simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The Company early adopted ASU 2020-06 as of February 1, 2021 using the modified retrospective approach. As a result of the adoption of ASU 2020-06, the Convertible Notes due July 2025 are no longer bifurcated into separate liability and equity components in the July 31, 2021 condensed consolidated balance sheets. Rather, the $287.5 million principal amount of the Company’s Convertible Notes was classified only as a liability in the July 31, 2021 condensed consolidated balance sheets. Upon adoption, the Company recognized an increase to long-term debt of $61.7 million, a decrease to additional paid in capital of $68.5 million, and a decrease in accumulated deficit of $6.7 million on its condensed consolidated balance sheets as of February 1, 2021. The adoption did not affect the Company’s condensed consolidated statements of operations or condensed consolidated statements of cash flows. Refer to Note 9. “Debt and Financing Instruments” for further information. As of January 31, 2021 ASU 2020-06 Adoption Adjustment As of February 1, 2021 (in thousands) Liabilities Outstanding principal $ 287,500 $ — $ 287,500 Unamortized debt discount and issuance costs (69,972) 61,736 (8,236) Net carrying amount $ 217,528 $ 61,736 $ 279,264 Equity Additional paid-in-capital $ (614,494) $ 68,478 $ (546,016) Accumulated deficit (248,110) 6,742 (241,368)

Cash, Cash Equivalents, and Inv

Cash, Cash Equivalents, and Investments	6 Months Ended
	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash, Cash Equivalents, and Investments	Cash, Cash Equivalents, and Investments Cash, cash equivalents, and investments consisted of the following: As of July 31, 2021 As of January 31, 2021 (in thousands) Cash and cash equivalents Cash $ 326,999 $ 184,308 Money market funds 27,526 139,870 U.S. Treasury securities — 14,988 Total cash and cash equivalents $ 354,525 $ 339,166 Available-for-sale investments: U.S. Treasury securities $ 50,390 $ 45,026 Commercial paper 24,635 34,598 Corporate debt securities 117,271 141,488 Total available-for-sale investments $ 192,296 $ 221,112 The following tables summarize the Company’s investments’ adjusted cost, net unrealized gains (losses), and fair value by significant investment category as of July 31, 2021 and January 31, 2021. Gross realized gains or losses from sales of available-for-sale securities were not material for the three and six months ended July 31, 2021. As of July 31, 2021 Cost Basis Unrealized Gain (Loss), Net Recorded Basis (in thousands) Available-for-sale investments: U.S. Treasury securities $ 50,392 $ (2) $ 50,390 Commercial paper 24,632 3 24,635 Corporate debt securities 117,241 30 117,271 Total available-for-sale investments $ 192,265 $ 31 $ 192,296 As of January 31, 2021 Cost Basis Unrealized Gain (Loss), Net Recorded Basis (in thousands) Available-for-sale investments: U.S. Treasury securities $ 45,023 $ 3 $ 45,026 Commercial paper 34,607 (9) 34,598 Corporate debt securities 141,139 349 141,488 Total available-for-sale investments $ 220,769 $ 343 $ 221,112 The following table presents the Company’s available-for-sale securities by contractual maturity date as of July 31, 2021 and January 31, 2021: As of July 31, 2021 Cost Basis Recorded Basis (in thousands) Due within one year $ 149,399 $ 149,458 Due between one to five years 42,866 42,838 Total $ 192,265 $ 192,296 As of January 31, 2021 Cost Basis Recorded Basis (in thousands) Due within one year $ 171,498 $ 171,837 Due between one to five years 49,271 49,275 Total $ 220,769 $ 221,112 When evaluating investments for impairment, the Company reviews factors such as the extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company’s intent to sell, or whether it is more likely than not that the Company will be required to sell, the investment before recovery of the investment’s amortized cost. No impairment loss has been recorded on the securities included in the tables above, as the Company believes that any decrease in fair value of these securities is temporary and the Company expects to recover at least up to the initial cost of the investment for these securities. The Company has not recorded an allowance for credit losses, as the Company believes any such losses would be immaterial based on the high-grade credit rating for each of its marketable securities as of the end of each period.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jul. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company measures its financial assets and liabilities at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value, as follows: Level 1—Valuations based on observable inputs that reflect quoted prices for identical assets or liabilities in active markets. Level 2—Valuations based on inputs that are directly or indirectly observable in the marketplace. Level 3—Valuations based on unobservable inputs that are supported by little or no market activity. The following table presents information about the Company’s financial assets that are required to be measured or disclosed at fair value using the above input categories: As of July 31, 2021 Level 1 Level 2 Level 3 Total (in thousands) Money market funds $ 27,526 $ — $ — $ 27,526 U.S. Treasury securities — 50,390 — 50,390 Commercial paper — 24,635 — 24,635 Corporate debt securities — 117,271 — 117,271 Total $ 27,526 $ 192,296 $ — $ 219,822 Included in cash equivalents $ 27,526 Included in investments $ 192,296 As of January 31, 2021 Level 1 Level 2 Level 3 Total (in thousands) Money market funds $ 139,870 $ — $ — $ 139,870 U.S. Treasury securities 14,988 45,026 — 60,014 Commercial paper — 34,598 — 34,598 Corporate debt securities — 141,488 — 141,488 Total $ 154,858 $ 221,112 $ — $ 375,970 Included in cash equivalents $ 154,858 Included in investments $ 221,112 The Company’s assets that are measured by management at fair value on a recurring basis are generally classified within Level 1 or Level 2 of the fair value hierarchy. The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. As of July 31, 2021 and January 31, 2021, the Company’s Level 2 securities were priced by pricing vendors. These pricing vendors utilize observable market information in pricing these securities or, if specific prices are not available for these securities, use other observable inputs like market transactions involving identical or comparable securities. The carrying amounts of certain financial instruments, including cash held in banks, accounts receivable, and accounts payable approximate fair value due to their short-term maturities and are excluded from the fair value table above. Convertible Senior Notes As of July 31, 2021, the estimated fair value of the Notes was approximately $364.2 million. The fair value was determined based on the quoted price for the Notes in an inactive market on the last trading day of the reporting period and is considered as Level 2 in the fair value hierarchy.

Goodwill and Acquired Intangibl

Goodwill and Acquired Intangible Assets	6 Months Ended
	Jul. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquired Intangible Assets	Goodwill and Acquired Intangible Assets There have been no changes in the carrying amount of goodwill since January 31, 2021. Acquired intangible assets subject to amortization as of July 31, 2021 were as follows: Cost Accumulated Amortization Net Weighted Average (in thousands) (in years) Customer relationships $ 21,800 $ (1,817) $ 19,983 9.2 Developed technology 5,600 (933) 4,667 4.2 Trademarks 400 (167) 233 1.2 Total acquired intangibles, net $ 27,800 $ (2,917) $ 24,883 For the three and six months ended July 31, 2021, amortization expense related to acquired intangible assets was $0.9 million, and $1.8 million, respectively. No amortization expense was recorded during the three and six months ended July 31, 2020.

Property and Equipment, Net

Property and Equipment, Net	6 Months Ended
	Jul. 31, 2021
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net, consisted of the following: As of July 31, 2021 As of January 31, 2021 (in thousands) Leasehold improvements $ 12,957 $ 12,767 Computers and equipment 7,510 6,562 Furniture and fixtures 3,002 3,017 Capitalized internal-use software 3,936 1,355 Gross property and equipment (1) 27,405 23,701 Accumulated depreciation and amortization (13,289) (11,062) Property and equipment, net $ 14,116 $ 12,639 (1) Gross property and equipment includes construction-in-progress for leasehold improvements of $0.7 million and $0.5 million that had not yet been placed in service as of July 31, 2021 and January 31, 2021, respectively. The costs associated with construction-in-progress are not amortized until the asset is available for its intended use. Depreciation and amortization expense was $1.1 million and $1.0 million for the three months ended July 31, 2021 and 2020, respectively, and $2.1 million and $1.9 million for the six months ended July 31, 2021 and 2020, respectively.

Deferred Contract Costs

Deferred Contract Costs	6 Months Ended
	Jul. 31, 2021
Revenue from Contract with Customer [Abstract]
Deferred Contract Costs	Deferred Contract CostsDeferred contract costs, which primarily consist of deferred sales commissions, were $34.3 million and $31.6 million as of July 31, 2021 and January 31, 2021, respectively. Amortization expense for deferred contract costs was $3.6 million and $2.6 million for the three months ended July 31, 2021 and 2020, respectively, and $6.8 million and $5.1 million for the six months ended July 31, 2021 and 2020, respectively. There was no impairment charge related to the costs capitalized for the periods presented.Deferred Revenue and Performance Obligations The following table presents the changes to the Company’s deferred revenue: Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands) Deferred revenue, beginning of period $ 126,056 $ 96,446 $ 129,972 $ 92,569 Billings 75,482 55,448 135,157 109,111 Revenue recognized (67,536) (50,714) (131,127) (100,500) Deferred revenue, end of period $ 134,002 $ 101,180 $ 134,002 $ 101,180 For the three and six months ended July 31, 2021 and 2020, the majority of revenue recognized was from the deferred revenue balances at the beginning of each quarter. As of July 31, 2021, future estimated revenue related to performance obligations for cloud-hosted and term-license software subscriptions with terms of more than one year that are unsatisfied or partially unsatisfied at the end of the reporting periods was approximately $118.2 million. The Company expects to satisfy the substantial majority of these unsatisfied performance obligations over the next 24 months and the remainder thereafter. The Company applied the optional exemption for subscriptions with terms of less than one year.

Leases

Leases	6 Months Ended
	Jul. 31, 2021
Leases [Abstract]
Leases	Leases Operating Leases The Company has entered into various non-cancellable operating leases for its office spaces with lease periods expiring between fiscal 2022 and fiscal 2029. The operating lease agreements generally provide for rental payments on a graduated basis and for options to renew, which could increase future minimum lease payments if exercised. Lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The lease right-of-use assets also include any lease payments made and exclude lease incentives such as tenant improvement allowances. The operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments. Leases with a term of one year or less are not recognized on our condensed consolidated balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. The following tables present information about leases on the condensed consolidated balance sheet. As of July 31, 2021 As of January 31, 2021 (in thousands) Assets Lease right-of-use assets $ 22,482 $ 24,691 Liabilities Lease liabilities 5,469 5,262 Lease liabilities, non-current 23,831 26,542 As of July 31, 2021, the weighted average remaining lease term was 5.3 years and the weighted average discount rate used to determine the net present value of the lease liabilities was 3.7%. The following table presents information about leases on the condensed consolidated statement of operations. Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands) Operating lease expense $ 1,403 $ 1,445 $ 2,772 $ 2,887 Short-term lease expense 79 261 169 560 Variable lease expense 202 361 315 663 The following table presents supplemental cash flow information about the Company’s leases. Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands) Cash paid for amounts included in the measurement of lease liabilities $ 1,571 $ 1,149 $ 3,143 $ 2,287

Debt and Financing Arrangements

Debt and Financing Arrangements	6 Months Ended
	Jul. 31, 2021
Debt Disclosure [Abstract]
Debt and Financing Arrangements	Debt and Financing Arrangements Convertible Senior Notes On June 25, 2020, the Company issued $287.5 million in aggregate principal amount of the Notes in a private offering pursuant to an Indenture dated June 25, 2020 (the “Indenture”). The total net proceeds from the debt offering, after deducting initial purchaser discounts and debt issuance costs, paid or payable by us, were $278.2 million. The Notes are senior, unsecured obligations of the Company and accrue interest payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2021, at a rate of 1.25% per year. The Notes will mature on July 1, 2025, unless such notes are converted, redeemed or repurchased earlier. The Notes are convertible into cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election in the manner and subject to the terms and conditions provided in the Indenture. Holders of the Notes may convert all or any portion of their Notes at their option at any time prior to the close of business on April 1, 2025, only under the following circumstances: • During any fiscal quarter commencing after the fiscal quarter ended October 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; • During the five business day period after any ten consecutive trading day period (the measurement period) in which the “trading price” (as defined in the Indenture) per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; • If the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or • Upon the occurrence of specified corporate events, as noted in the Indenture. On or after April 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, regardless of the foregoing circumstances. The conversion rate will initially be 24.9507 shares of common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $40.08 per share of common stock. The conversion rate is subject to adjustment under certain circumstances in accordance with the terms of the Indenture, but will not be adjusted for accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Notes in connection with such a fundamental change, as defined in the Indenture. The Company may not redeem the Notes prior to July 6, 2023. The Company may redeem for cash all or any portion of the Notes, at its option, on a redemption date occurring on or after July 6, 2023 and prior to the 41st scheduled trading day immediately preceding the maturity date, if the last reported sale price of the common stock has been at least 130% of the conversion price for the Notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Notes. If the Company undergoes a fundamental change (as defined in the Indenture), holders may require the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The Indenture contains customary terms and covenants, including that upon certain events of default occurring and continuing, the trustee or the holders of at least 25% in aggregate principal amount of the outstanding Notes may declare the entire principal of all the Notes plus accrued and unpaid interest to be immediately due and payable. Prior to the adoption of ASU 2020-06 on February 1, 2021 and in accounting for the issuance of the Notes, the Company separated the Notes into liability and equity components. The carrying amount of the liability component was calculated using a discount rate of 7.30%, which was determined by measuring the fair value of a similar debt instrument that does not have an associated conversion feature. The carrying amount of the equity component representing the conversion option was $70.8 million and was determined by deducting the fair value of the liability component from the par value of the Notes. The equity component was not remeasured as long as it continued to meet the conditions for equity classification, and the equity component was recorded in additional paid-in-capital in the accompanying condensed consolidated balance sheet. The excess of the principal amount of the liability component over its carrying amount, or the debt discount, was amortized to interest expense at an annual effective interest rate of 7.88% over the contractual terms of the Notes. The interest rate was based on the interest rate of similar liabilities at the time of issuance that did not have associated convertible features. The debt component was classified as a long-term liability as of January 31, 2021. Prior to the adoption of ASU 2020-06 on February 1, 2021 and in accounting for the issuance costs of $9.3 million related to the Notes, the Company allocated the total amount incurred to the liability and equity components of the Notes based on their relative values. Issuance costs attributable to the liability component were $7.0 million and were amortized to interest expense using the effective interest method over the contractual term of the Notes. Issuance costs attributable to the equity component were $2.3 million and were netted with the equity component in additional paid-in capital. On February 1, 2021, the Company elected to early adopt ASU 2020-06 based on a modified retrospective transition method. Under such transition, prior-period information has not been retrospectively adjusted. In accounting for the Notes after adoption of ASU 2020-06, the Notes are accounted for as a single liability, and the carrying amount of the Notes is $280.2 million as of July 31, 2021, with principal of $287.5 million, net of unamortized issuance costs of $7.3 million. The Notes were classified as long term liabilities as of July 31, 2021. The issuance costs related to the Notes are being amortized to interest expense over the contractual term of the Notes at an effective interest rate of 1.93%. The net carrying amount of the liability component of the Notes as of July 31, 2021 (post-ASU 2020-06 adoption) and as of January 31, 2021 (pre-ASU 2020-06 adoption) was as follows: As of July 31, 2021 As of January 31, 2021 (in thousands) Principal $ 287,500 $ 287,500 Less: unamortized debt discount — (63,664) Less: unamortized issuance costs (7,338) (6,308) Net carrying amount $ 280,162 $ 217,528 The net carrying amount of the equity component of the Notes as of July 31, 2021 (post-ASU 2020-06 adoption) and as of January 31, 2021 (pre-ASU 2020-06 adoption) was as follows: As of July 31, 2021 As of January 31, 2021 (in thousands) Proceeds allocated to the conversion options (debt discount) $ — $ 70,768 Less: issuance costs — (2,290) Carrying amount of the equity component $ — $ 68,478 Interest expense recognized related to the Notes is as follows: Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands) Contractual interest expense $ 918 $ 349 $ 1,797 $ 349 Amortization of debt discount — 1,145 — 1,145 Amortization of debt issuance costs 460 114 898 114 Total interest expense related to the Notes $ 1,378 $ 1,608 $ 2,695 $ 1,608 Capped Call Transactions In connection with the offering of the Notes, the Company entered into privately negotiated capped call transactions (the “Capped Calls”) with certain financial institution counterparties (the “Option Counterparties”). The Capped Calls are generally intended to reduce or offset the potential dilution to the common stock upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. For accounting purposes, the Capped Calls are separate transactions, and not part of the terms of the Notes. The Capped Calls are recorded in stockholders’ equity and are not accounted for as derivatives. The cost of $35.7 million incurred to purchase the Capped Calls were recorded as a reduction to additional paid-in capital in the accompanying condensed consolidated balance sheet. The Capped Calls each have an initial strike price of approximately $40.08 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have an initial cap price of $61.66 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, approximately 7.2 million shares of our common stock. The Capped Calls are subject to automatic exercise over a 40 trading day period commencing on May 2, 2025, subject to earlier termination under certain circumstances.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal Matters From time to time in the normal course of business, the Company may be subject to various claims and other legal matters arising in the ordinary course of business. The Company investigates these claims as they arise and accrues estimates for resolution of legal and other contingencies when losses are probable and estimable. The Company is not currently a party to any legal proceedings and does not anticipate any pending or threatened litigation that would be expected to have a material adverse effect on its financial condition, results of operations, or cash flows. Warranties and Indemnification The Company has entered into service-level agreements with a portion of its customers defining levels of uptime reliability and performance and permitting those customers to receive credits if the Company fails to meet the defined levels of uptime. To date, the Company has not experienced any significant failures to meet defined levels of uptime reliability and performance as a result of those agreements and, as a result, the Company has not incurred or accrued any material liabilities related to these agreements in the financial statements.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	6 Months Ended
	Jul. 31, 2021
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Deferred Contract CostsDeferred contract costs, which primarily consist of deferred sales commissions, were $34.3 million and $31.6 million as of July 31, 2021 and January 31, 2021, respectively. Amortization expense for deferred contract costs was $3.6 million and $2.6 million for the three months ended July 31, 2021 and 2020, respectively, and $6.8 million and $5.1 million for the six months ended July 31, 2021 and 2020, respectively. There was no impairment charge related to the costs capitalized for the periods presented.Deferred Revenue and Performance Obligations The following table presents the changes to the Company’s deferred revenue: Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands) Deferred revenue, beginning of period $ 126,056 $ 96,446 $ 129,972 $ 92,569 Billings 75,482 55,448 135,157 109,111 Revenue recognized (67,536) (50,714) (131,127) (100,500) Deferred revenue, end of period $ 134,002 $ 101,180 $ 134,002 $ 101,180 For the three and six months ended July 31, 2021 and 2020, the majority of revenue recognized was from the deferred revenue balances at the beginning of each quarter. As of July 31, 2021, future estimated revenue related to performance obligations for cloud-hosted and term-license software subscriptions with terms of more than one year that are unsatisfied or partially unsatisfied at the end of the reporting periods was approximately $118.2 million. The Company expects to satisfy the substantial majority of these unsatisfied performance obligations over the next 24 months and the remainder thereafter. The Company applied the optional exemption for subscriptions with terms of less than one year.

Common Stock and Stockholders'

Common Stock and Stockholders' Equity	6 Months Ended
	Jul. 31, 2021
Equity [Abstract]
Common Stock and Stockholders' Equity	Common Stock and Stockholders’ Equity Equity Incentive Plans The Company has two equity incentive plans: the 2010 Stock Plan (the “2010 Plan”) and the 2019 Equity Incentive Plan (the “2019 Plan”, collectively the “Stock Plans”). Upon completion of the Company’s IPO in April 2019, the Company ceased granting awards under the 2010 Plan, and all shares that remained available for future issuance under the 2010 Plan at that time were transferred to the 2019 Plan. The 2019 Plan superseded and replaced the 2010 Plan. As of July 31, 2021 and January 31, 2021, the Company was authorized to grant up to 22,964,193 shares and 18,059,506 shares of common stock, respectively, under the Stock Plans. The Company currently uses authorized and unissued shares to satisfy stock award exercises. As of July 31, 2021 and January 31, 2021, there were 15,693,636 shares and 13,060,282 shares available for future issuance under the Stock Plans, respectively. Shares of common stock reserved for future issuance are as follows: July 31, 2021 Outstanding stock options and unvested RSUs and PSUs outstanding 14,965,580 Available for future stock option, RSU, and PSU grants 15,693,636 Available for ESPP 2,721,649 Total common stock reserved at July 31, 2021 33,380,865 Stock Option Activity Stock option activity is as follows: Number of Weighted Weighted Aggregate (in thousands) Outstanding at January 31, 2021 11,177,838 $ 8.25 6.9 years $ 452,452 Granted 48,866 $ 41.52 Exercised (1,286,266) $ 6.36 Canceled (283,443) $ 16.61 Outstanding at July 31, 2021 9,656,995 $ 8.43 6.5 years $ 310,586 Vested as of July 31, 2021 7,153,532 $ 6.23 6.1 years $ 245,762 The Company uses the Black-Scholes option-pricing model to estimate the fair value of stock options on the date of grant. The Company accounts for forfeitures as they occur. The following assumptions were used to calculate the fair value of employee stock option grants made during the periods: Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 Expected dividend yield — % — % — % — % Expected volatility 46.5% 43.9 % 43.8% - 46.5% 43.3% - 43.9% Expected term (years) 6.1 6.1 6.1 6.1 Risk-free interest rate 1.04% 0.41% 1.04% - 1.16% 0.41% - 0.47% Stock options granted during the three months ended July 31, 2021 and 2020 had a weighted average grant date fair value of $19.08 and $12.59 per share, respectively. The aggregate intrinsic value of stock options exercised during the three months ended July 31, 2021 and 2020 was $25.6 million and $11.6 million, respectively. Stock options granted during the six months ended July 31, 2021 and 2020 had a weighted average grant date fair value of $18.23 and $8.96 per share, respectively. The aggregate intrinsic value of stock options exercised during the six months ended July 31, 2021 and 2020 was $46.1 million and $23.0 million, respectively. The intrinsic value for options exercised is the difference between the market value of the stock and the exercise price of the stock option at the date of exercise. As of July 31, 2021, there was approximately $23.5 million of total unrecognized compensation cost related to unvested stock options granted under the Stock Plans, which will be recognized over a weighted average period of 2.3 years. Restricted Stock Units A summary of the Company’s RSU activity and related information is as follows: Number of RSUs Weighted Outstanding at January 31, 2021 3,971,128 $ 23.60 Granted 2,127,307 $ 41.31 Vested (407,887) $ 23.84 Canceled (636,581) $ 26.43 Outstanding at July 31, 2021 5,053,967 $ 30.68 The Company uses the fair value of RSUs based on the fair value of the underlying shares on the date of grant. The Company accounts for forfeitures as they occur. As of July 31, 2021, there was $145.2 million of unrecognized stock-based compensation expense related to unvested RSUs, which is expected to be recognized over a weighted average period of 3.3 years based on vesting under the award service conditions. Performance Stock Units In April 2021, the Company granted 127,309 PSUs, with a weighted-average grant date fair value of $41.17 per share, to certain employees of the Company for which the ultimate number of units that will vest are determined based on the achievement of performance at the end of the stated performance period. The performance condition is based on the level of achievement of a Company target related to PagerDuty’s operating plan for fiscal 2022 ("2022 operating plan"). The PSUs will vest over a three-year period, subject to continuous service with the Company. During the three and six months ended July 31, 2021, the Company recorded stock-based compensation expense for the number of PSUs considered probable of vesting based on the expected attainment of the performance targets. As of July 31, 2021, total unrecognized stock-based compensation cost related to PSUs was $3.4 million. This unrecognized stock-based compensation cost is expected to be recognized using the accelerated attribution method over a weighted-average period of approximately 1.5 years. Employee Stock Purchase Plan In April 2019, the Board of Directors adopted and approved the 2019 Employee Stock Purchase Plan, which became effective on April 11, 2019. The ESPP generally provides for 24-month offering periods beginning June 15 and December 15 of each year, with each offering period consisting of four six-month purchase periods. On each purchase date, eligible employees will purchase the shares at a price per share equal to 85% of the lesser of (1) the fair market value of the Company’s stock as of the beginning of the offering period or (2) the fair market value of the Company’s stock on the purchase date, as defined in the ESPP. During the three months ended July 31, 2021 and 2020, the Company recognized $1.3 million and $1.2 million of stock-based compensation expense related to the ESPP, respectively. During the six months ended July 31, 2021 and 2020, the Company recognized $3.1 million and $2.8 million of stock-based compensation expense related to the ESPP, respectively. During the three months ended July 31, 2021 and 2020, the Company withheld $2.0 million and $1.6 million in contributions from employees, respectively. During the six months ended July 31, 2021 and 2020, the Company withheld $5.0 million and $3.5 million, respectively. During the three and six months ended July 31, 2021, 171,796, 20,269, and 30,409 shares of common stock were issued under the ESPP at purchase prices of $19.63, $23.03, and $34.54, respectively. During the three and six months ended July 31, 2020, 181,253 shares of common stock were issued under the ESPP at a purchase price of $19.63 per share. Stock-Based Compensation Stock-based compensation expense included in the Company’s condensed consolidated statements of operations is as follows: Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands) Cost of revenue $ 1,023 $ 263 $ 1,699 $ 607 Research and development 5,607 2,469 10,047 4,652 Sales and marketing 4,401 2,870 8,355 5,155 General and administrative 5,445 4,366 9,987 7,862 Total $ 16,476 $ 9,968 $ 30,088 $ 18,276

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jul. 31, 2021
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss per Share The following table presents the calculation of basic and diluted net loss per share: Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands, except per share data) Numerator: Net loss $ (29,661) $ (14,688) $ (52,219) $ (26,147) Denominator: Weighted average shares used in calculating net loss per share, basic and diluted 83,895 78,775 83,413 78,278 Net loss per share, basic and diluted $ (0.35) $ (0.19) $ (0.63) $ (0.33) Since the Company was in a loss position for the periods presented, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: As of July 31, 2021 2020 (in thousands) Shares subject to outstanding common stock awards 14,838 16,298 Convertible senior notes 7,173 7,173 Restricted stock awards purchased with promissory notes — 142 Restricted stock issued to Rundeck key personnel 191 — Shares issuable pursuant to the 2019 Employee Stock Purchase Plan 72 64 Total 22,274 23,677

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company's provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period. The Company's quarterly tax provision, and estimate of its annual effective tax rate, is subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income (or loss) relates, changes in how the Company does business, and tax law developments. The Company's estimated effective tax rate for the year differs from the U.S. statutory rate of 21% as a result of our U.S. losses for which no benefit will be realized, our foreign operations which are subject to tax rates that differ from those in the U.S, as well as the benefit for non-U.S. income tax credits. The Company recorded income tax expense of $0.2 million for the three months ended July 31, 2020, and $0.2 million and $0.5 million for the six months ended July 31, 2021 and 2020, respectively. Income tax expense for the three months ended July 31, 2021 was not material.

Geographic Information

Geographic Information	6 Months Ended
	Jul. 31, 2021
Segment Reporting [Abstract]
Geographic Information	Geographic Information Revenue by location is determined by the billing address of the customer. The following table sets forth revenue by geographic area: Three Months Ended July 31, Six Months Ended July 31, 2021 2021 2020 2021 2020 (in thousands) United States $ 51,019 $ 38,997 $ 98,761 $ 77,269 International 16,517 11,717 32,366 23,231 Total $ 67,536 $ 50,714 $ 131,127 $ 100,500

Subsequent Events

Subsequent Events	6 Months Ended
	Jul. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsThe Company has evaluated subsequent events through September 3, 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet as of January 31, 2021 was derived from the audited consolidated financial statements as of that date but does not include all of the information and notes required by GAAP for complete financial statements. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended January 31, 2021, included in the Company’s Annual Report on Form 10-K, filed with the SEC. The condensed consolidated financial statements include the results of PagerDuty, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of management, the information contained herein reflects all adjustments necessary for a fair presentation of the Company’s results of operations, financial position, cash flows, and statements of stockholders’ equity. The results of operations for the three and six months ended July 31, 2021 are not necessarily indicative of the results to be expected for the full year ending January 31, 2022 or for any other interim period, or for any future year. The Company’s fiscal year ends on January 31. References to fiscal 2022, for example, refer to the fiscal year ending January 31, 2022.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make, on an ongoing basis, estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The Company’s most significant estimates and judgments involve the fair value of stock awards, period of benefit for amortizing deferred contract costs, the determination of the allowance for doubtful accounts, the provision for income taxes, including the related valuation allowance and any uncertain tax positions, fair value of acquired assets and assumed liabilities, impairment of goodwill and intangible assets, the incremental borrowing rate for lease liabilities, and estimates related to our revenue recognition, such as the assessment of performance obligations in our revenue arrangements and the fair value assigned to each performance obligation, among others. Management bases its
Concentrations of Risk and Significant Customers	Concentrations of Risk and Significant Customers The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, available-for-sale investments, and accounts receivable. All of the Company’s cash and cash equivalents and investments are invested in money market funds, United States (“U.S.”) Treasury securities, commercial paper, corporate debt securities, or U.S. Government agency securities that management believes to be of high credit quality.
Segment Information	Segment Information The Company manages its operations and allocates resources as one operating segment. The Company’s chief operating decision maker (“CODM”) is its chief executive officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes compensation expense for all stock-based payment awards, including stock options, restricted stock units (“RSUs”), and performance stock units (“PSUs”), based on the estimated fair value of the award on the grant date. The Company estimates the fair value of stock options issued to employees on the date of grant using the Black-Scholes option pricing model, which is impacted by the estimated fair value of the Company’s common stock, as well as certain assumptions including the expected volatility over the term of the option awards, the expected term of the awards, risk-free interest rates and the expected dividend yield. Assumptions and estimates used in the determination of the fair value of stock options are as follows: Expected volatility —Expected volatility is a measure of the amount by which the stock price is expected to fluctuate. Since the Company does not have sufficient trading history for its common stock, it estimates the expected volatility of its stock options by taking the average historical volatility of a group of comparable publicly traded companies over a period equal to the expected life of the options. Expected term —The Company determines the expected term based on the average period the stock options are expected to remain outstanding, generally calculated as the midpoint of the stock options’ vesting term and contractual expiration period, as the Company does not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. Risk-free rate —The Company uses the U.S. Treasury yield for its risk-free interest rate that corresponds with the expected term. Expected dividend yield —The Company utilizes a dividend yield of zero, as it does not currently issue dividends and does not expect to in the future. The Company estimates the fair value of RSUs and PSUs at our stock price on the grant date. The Company estimates the fair value of shares to be issued under the employee stock purchase plan (the “ESPP”) on the first day of the offering period using the Black-Scholes valuation model, which is impacted by the estimated fair value of the Company’s common stock, as well as certain assumptions including the expected volatility over the term of the offering period, the expected term of the awards, risk-free interest rates and the expected dividend yield. Assumptions used in the determination of the fair value of the ESPP are the same as those used in the determination of the fair value of our stock options. The Company generally recognizes compensation expense for employee stock-based payment awards on a straight-line basis over the period during which an award recipient is required to provide services in exchange for the award (generally the vesting period of the award), with the exception of PSUs which are recognized using the accelerated attribution method. The Company accounts for forfeitures as they occur. The fair value of each non-employee stock option is estimated at the date of grant using the Black-Scholes option pricing model and is not remeasured over the vesting term. Assumptions used in valuing non-employee stock options are generally consistent with those used for employee stock options with the exception that the expected term is over the contractual life.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In August 2020, the FASB issued Accounting Standard Update No. 2020-06, Debt—Debt with Conversion Options (“Subtopic 470-20”) and Derivatives and Hedging—Contracts in Entity’s Own Equity (“Subtopic 815-40”)
Operating Leases	Operating Leases The Company has entered into various non-cancellable operating leases for its office spaces with lease periods expiring between fiscal 2022 and fiscal 2029. The operating lease agreements generally provide for rental payments on a graduated basis and for options to renew, which could increase future minimum lease payments if exercised. Lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The lease right-of-use assets also include any lease payments made and exclude lease incentives such as tenant improvement allowances. The operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jul. 31, 2021
Accounting Policies [Abstract]
Accounting Standards Update and Change in Accounting Principle	As of January 31, 2021 ASU 2020-06 Adoption Adjustment As of February 1, 2021 (in thousands) Liabilities Outstanding principal $ 287,500 $ — $ 287,500 Unamortized debt discount and issuance costs (69,972) 61,736 (8,236) Net carrying amount $ 217,528 $ 61,736 $ 279,264 Equity Additional paid-in-capital $ (614,494) $ 68,478 $ (546,016) Accumulated deficit (248,110) 6,742 (241,368)

Cash, Cash Equivalents, and I_2

Cash, Cash Equivalents, and Investments (Tables)	6 Months Ended
	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Components of Cash and Cash Equivalents	Cash, cash equivalents, and investments consisted of the following: As of July 31, 2021 As of January 31, 2021 (in thousands) Cash and cash equivalents Cash $ 326,999 $ 184,308 Money market funds 27,526 139,870 U.S. Treasury securities — 14,988 Total cash and cash equivalents $ 354,525 $ 339,166 Available-for-sale investments: U.S. Treasury securities $ 50,390 $ 45,026 Commercial paper 24,635 34,598 Corporate debt securities 117,271 141,488 Total available-for-sale investments $ 192,296 $ 221,112
Components of Available-for-sale Investments	Cash, cash equivalents, and investments consisted of the following: As of July 31, 2021 As of January 31, 2021 (in thousands) Cash and cash equivalents Cash $ 326,999 $ 184,308 Money market funds 27,526 139,870 U.S. Treasury securities — 14,988 Total cash and cash equivalents $ 354,525 $ 339,166 Available-for-sale investments: U.S. Treasury securities $ 50,390 $ 45,026 Commercial paper 24,635 34,598 Corporate debt securities 117,271 141,488 Total available-for-sale investments $ 192,296 $ 221,112
Components of Held-to-maturity Investments	Cash, cash equivalents, and investments consisted of the following: As of July 31, 2021 As of January 31, 2021 (in thousands) Cash and cash equivalents Cash $ 326,999 $ 184,308 Money market funds 27,526 139,870 U.S. Treasury securities — 14,988 Total cash and cash equivalents $ 354,525 $ 339,166 Available-for-sale investments: U.S. Treasury securities $ 50,390 $ 45,026 Commercial paper 24,635 34,598 Corporate debt securities 117,271 141,488 Total available-for-sale investments $ 192,296 $ 221,112 The following tables summarize the Company’s investments’ adjusted cost, net unrealized gains (losses), and fair value by significant investment category as of July 31, 2021 and January 31, 2021. Gross realized gains or losses from sales of available-for-sale securities were not material for the three and six months ended July 31, 2021. As of July 31, 2021 Cost Basis Unrealized Gain (Loss), Net Recorded Basis (in thousands) Available-for-sale investments: U.S. Treasury securities $ 50,392 $ (2) $ 50,390 Commercial paper 24,632 3 24,635 Corporate debt securities 117,241 30 117,271 Total available-for-sale investments $ 192,265 $ 31 $ 192,296 As of January 31, 2021 Cost Basis Unrealized Gain (Loss), Net Recorded Basis (in thousands) Available-for-sale investments: U.S. Treasury securities $ 45,023 $ 3 $ 45,026 Commercial paper 34,607 (9) 34,598 Corporate debt securities 141,139 349 141,488 Total available-for-sale investments $ 220,769 $ 343 $ 221,112
Summary of Carrying Value of Available-for-sale Investments	The following tables summarize the Company’s investments’ adjusted cost, net unrealized gains (losses), and fair value by significant investment category as of July 31, 2021 and January 31, 2021. Gross realized gains or losses from sales of available-for-sale securities were not material for the three and six months ended July 31, 2021. As of July 31, 2021 Cost Basis Unrealized Gain (Loss), Net Recorded Basis (in thousands) Available-for-sale investments: U.S. Treasury securities $ 50,392 $ (2) $ 50,390 Commercial paper 24,632 3 24,635 Corporate debt securities 117,241 30 117,271 Total available-for-sale investments $ 192,265 $ 31 $ 192,296 As of January 31, 2021 Cost Basis Unrealized Gain (Loss), Net Recorded Basis (in thousands) Available-for-sale investments: U.S. Treasury securities $ 45,023 $ 3 $ 45,026 Commercial paper 34,607 (9) 34,598 Corporate debt securities 141,139 349 141,488 Total available-for-sale investments $ 220,769 $ 343 $ 221,112
Summary of Contractual Maturities of Available-for-sale Securities	The following table presents the Company’s available-for-sale securities by contractual maturity date as of July 31, 2021 and January 31, 2021: As of July 31, 2021 Cost Basis Recorded Basis (in thousands) Due within one year $ 149,399 $ 149,458 Due between one to five years 42,866 42,838 Total $ 192,265 $ 192,296 As of January 31, 2021 Cost Basis Recorded Basis (in thousands) Due within one year $ 171,498 $ 171,837 Due between one to five years 49,271 49,275 Total $ 220,769 $ 221,112

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jul. 31, 2021
Fair Value Disclosures [Abstract]
Summary of Information about Company's Financial Assets	The following table presents information about the Company’s financial assets that are required to be measured or disclosed at fair value using the above input categories: As of July 31, 2021 Level 1 Level 2 Level 3 Total (in thousands) Money market funds $ 27,526 $ — $ — $ 27,526 U.S. Treasury securities — 50,390 — 50,390 Commercial paper — 24,635 — 24,635 Corporate debt securities — 117,271 — 117,271 Total $ 27,526 $ 192,296 $ — $ 219,822 Included in cash equivalents $ 27,526 Included in investments $ 192,296 As of January 31, 2021 Level 1 Level 2 Level 3 Total (in thousands) Money market funds $ 139,870 $ — $ — $ 139,870 U.S. Treasury securities 14,988 45,026 — 60,014 Commercial paper — 34,598 — 34,598 Corporate debt securities — 141,488 — 141,488 Total $ 154,858 $ 221,112 $ — $ 375,970 Included in cash equivalents $ 154,858 Included in investments $ 221,112

Goodwill and Acquired Intangi_2

Goodwill and Acquired Intangible Assets (Tables)	6 Months Ended
	Jul. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Other Intangible Assets Subject to Amortization	Acquired intangible assets subject to amortization as of July 31, 2021 were as follows: Cost Accumulated Amortization Net Weighted Average (in thousands) (in years) Customer relationships $ 21,800 $ (1,817) $ 19,983 9.2 Developed technology 5,600 (933) 4,667 4.2 Trademarks 400 (167) 233 1.2 Total acquired intangibles, net $ 27,800 $ (2,917) $ 24,883

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	6 Months Ended
	Jul. 31, 2021
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and equipment, net, consisted of the following: As of July 31, 2021 As of January 31, 2021 (in thousands) Leasehold improvements $ 12,957 $ 12,767 Computers and equipment 7,510 6,562 Furniture and fixtures 3,002 3,017 Capitalized internal-use software 3,936 1,355 Gross property and equipment (1) 27,405 23,701 Accumulated depreciation and amortization (13,289) (11,062) Property and equipment, net $ 14,116 $ 12,639 (1) Gross property and equipment includes construction-in-progress for leasehold improvements of $0.7 million and $0.5 million that had not yet been placed in service as of July 31, 2021 and January 31, 2021, respectively. The costs associated with construction-in-progress are not amortized until the asset is available for its intended use.

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jul. 31, 2021
Leases [Abstract]
Information About Lease on Condensed Consolidated Balance Sheet	The following tables present information about leases on the condensed consolidated balance sheet. As of July 31, 2021 As of January 31, 2021 (in thousands) Assets Lease right-of-use assets $ 22,482 $ 24,691 Liabilities Lease liabilities 5,469 5,262 Lease liabilities, non-current 23,831 26,542
Information About Leases on Condensed Consolidated Statement of Operations and Supplemental Cash Flow Information	The following table presents information about leases on the condensed consolidated statement of operations. Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands) Operating lease expense $ 1,403 $ 1,445 $ 2,772 $ 2,887 Short-term lease expense 79 261 169 560 Variable lease expense 202 361 315 663 The following table presents supplemental cash flow information about the Company’s leases. Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands) Cash paid for amounts included in the measurement of lease liabilities $ 1,571 $ 1,149 $ 3,143 $ 2,287

Debt and Financing Arrangemen_2

Debt and Financing Arrangements (Tables)	6 Months Ended
	Jul. 31, 2021
Debt Disclosure [Abstract]
Net Carrying Amount of Liability and Equity Components of Convertible Notes	The net carrying amount of the liability component of the Notes as of July 31, 2021 (post-ASU 2020-06 adoption) and as of January 31, 2021 (pre-ASU 2020-06 adoption) was as follows: As of July 31, 2021 As of January 31, 2021 (in thousands) Principal $ 287,500 $ 287,500 Less: unamortized debt discount — (63,664) Less: unamortized issuance costs (7,338) (6,308) Net carrying amount $ 280,162 $ 217,528 The net carrying amount of the equity component of the Notes as of July 31, 2021 (post-ASU 2020-06 adoption) and as of January 31, 2021 (pre-ASU 2020-06 adoption) was as follows: As of July 31, 2021 As of January 31, 2021 (in thousands) Proceeds allocated to the conversion options (debt discount) $ — $ 70,768 Less: issuance costs — (2,290) Carrying amount of the equity component $ — $ 68,478 Interest expense recognized related to the Notes is as follows: Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands) Contractual interest expense $ 918 $ 349 $ 1,797 $ 349 Amortization of debt discount — 1,145 — 1,145 Amortization of debt issuance costs 460 114 898 114 Total interest expense related to the Notes $ 1,378 $ 1,608 $ 2,695 $ 1,608

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations (Tables)	6 Months Ended
	Jul. 31, 2021
Revenue from Contract with Customer [Abstract]
Summary of Deferred Revenue	The following table presents the changes to the Company’s deferred revenue: Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands) Deferred revenue, beginning of period $ 126,056 $ 96,446 $ 129,972 $ 92,569 Billings 75,482 55,448 135,157 109,111 Revenue recognized (67,536) (50,714) (131,127) (100,500) Deferred revenue, end of period $ 134,002 $ 101,180 $ 134,002 $ 101,180

Common Stock and Stockholders_2

Common Stock and Stockholders' Equity (Tables)	6 Months Ended
	Jul. 31, 2021
Equity [Abstract]
Summary of Shares of Common Stock Reserved for Future Issuance	Shares of common stock reserved for future issuance are as follows: July 31, 2021 Outstanding stock options and unvested RSUs and PSUs outstanding 14,965,580 Available for future stock option, RSU, and PSU grants 15,693,636 Available for ESPP 2,721,649 Total common stock reserved at July 31, 2021 33,380,865
Schedule of Stock Option Activity	Stock option activity is as follows: Number of Weighted Weighted Aggregate (in thousands) Outstanding at January 31, 2021 11,177,838 $ 8.25 6.9 years $ 452,452 Granted 48,866 $ 41.52 Exercised (1,286,266) $ 6.36 Canceled (283,443) $ 16.61 Outstanding at July 31, 2021 9,656,995 $ 8.43 6.5 years $ 310,586 Vested as of July 31, 2021 7,153,532 $ 6.23 6.1 years $ 245,762
Schedule of Assumptions Used to Calculate Fair Value of Employee Stock Option Grants Made	The following assumptions were used to calculate the fair value of employee stock option grants made during the periods: Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 Expected dividend yield — % — % — % — % Expected volatility 46.5% 43.9 % 43.8% - 46.5% 43.3% - 43.9% Expected term (years) 6.1 6.1 6.1 6.1 Risk-free interest rate 1.04% 0.41% 1.04% - 1.16% 0.41% - 0.47%
Schedule of Restricted Stock Unit Activity	A summary of the Company’s RSU activity and related information is as follows: Number of RSUs Weighted Outstanding at January 31, 2021 3,971,128 $ 23.60 Granted 2,127,307 $ 41.31 Vested (407,887) $ 23.84 Canceled (636,581) $ 26.43 Outstanding at July 31, 2021 5,053,967 $ 30.68
Schedule of Stock-based Compensation Expense	Stock-based compensation expense included in the Company’s condensed consolidated statements of operations is as follows: Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands) Cost of revenue $ 1,023 $ 263 $ 1,699 $ 607 Research and development 5,607 2,469 10,047 4,652 Sales and marketing 4,401 2,870 8,355 5,155 General and administrative 5,445 4,366 9,987 7,862 Total $ 16,476 $ 9,968 $ 30,088 $ 18,276

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jul. 31, 2021
Earnings Per Share [Abstract]
Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share: Three Months Ended July 31, Six Months Ended July 31, 2021 2020 2021 2020 (in thousands, except per share data) Numerator: Net loss $ (29,661) $ (14,688) $ (52,219) $ (26,147) Denominator: Weighted average shares used in calculating net loss per share, basic and diluted 83,895 78,775 83,413 78,278 Net loss per share, basic and diluted $ (0.35) $ (0.19) $ (0.63) $ (0.33)
Schedule of Anti-dilutive Securities That Were Not Included in Diluted Per Share Calculations	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: As of July 31, 2021 2020 (in thousands) Shares subject to outstanding common stock awards 14,838 16,298 Convertible senior notes 7,173 7,173 Restricted stock awards purchased with promissory notes — 142 Restricted stock issued to Rundeck key personnel 191 — Shares issuable pursuant to the 2019 Employee Stock Purchase Plan 72 64 Total 22,274 23,677

Geographic Information (Tables)

Geographic Information (Tables)	6 Months Ended
	Jul. 31, 2021
Segment Reporting [Abstract]
Disaggregation of Revenue By Geographic Location	Revenue by location is determined by the billing address of the customer. The following table sets forth revenue by geographic area: Three Months Ended July 31, Six Months Ended July 31, 2021 2021 2020 2021 2020 (in thousands) United States $ 51,019 $ 38,997 $ 98,761 $ 77,269 International 16,517 11,717 32,366 23,231 Total $ 67,536 $ 50,714 $ 131,127 $ 100,500

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details)	3 Months Ended	6 Months Ended
	Jul. 31, 2021USD ($)	Jul. 31, 2021USD ($)segment	Apr. 30, 2021USD ($)	Feb. 01, 2021USD ($)	Jan. 31, 2021USD ($)	Jul. 31, 2020USD ($)	Jun. 25, 2020USD ($)	Apr. 30, 2020USD ($)	Jan. 31, 2020USD ($)
Accounting Policies [Abstract]
Number of operating segments | segment		1
Related party transaction, receivable	$ 1,100,000	$ 1,100,000
Expected dividend yield		0.00%
Item Effected [Line Items]
Convertible senior notes, net	280,162,000	$ 280,162,000		$ 279,264,000	$ 217,528,000
Accumulated deficit	285,172,000	285,172,000	$ 294,056,000		366,727,000	$ 341,871,000		$ 307,543,000	$ 307,938,000
Accumulated Deficit
Item Effected [Line Items]
Accumulated deficit	(293,587,000)	(293,587,000)	(263,926,000)		(248,110,000)	(205,354,000)		(190,666,000)	(179,207,000)
Additional Paid-in Capital
Item Effected [Line Items]
Accumulated deficit	578,728,000	578,728,000	$ 557,843,000		614,494,000	$ 546,169,000		$ 497,430,000	$ 487,008,000
Cumulative Effect, Period of Adoption, Adjustment
Item Effected [Line Items]
Accumulated deficit					(61,736,000)
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit
Item Effected [Line Items]
Accumulated deficit					6,742,000
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-in Capital
Item Effected [Line Items]
Accumulated deficit					(68,478,000)
Accounting Standards Update 2020-06
Item Effected [Line Items]
Convertible senior notes, net					$ 61,700,000
Convertible Senior Notes
Item Effected [Line Items]
Aggregate principal amount of debt issued	$ 287,500,000	$ 287,500,000					$ 287,500,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Adjusted Financial Statements to Apply Adopted Guidance (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Feb. 01, 2021	Jan. 31, 2021
Liabilities
Principal		$ 287,500
Unamortized debt discount and issuance costs		(8,236)
Net carrying amount	$ 280,162	279,264	$ 217,528
Equity
Additional paid-in capital	(578,728)	(546,016)	(614,494)
Accumulated deficit	$ (293,587)	$ (241,368)	(248,110)
Accounting Standards Update 2020-06
Liabilities
Net carrying amount			61,700
Previously Reported
Liabilities
Principal			287,500
Unamortized debt discount and issuance costs			(69,972)
Net carrying amount			217,528
Equity
Additional paid-in capital			(614,494)
Accumulated deficit			(248,110)
ASU 2020-06 Adoption Adjustment | Accounting Standards Update 2020-06
Liabilities
Principal			0
Unamortized debt discount and issuance costs			61,736
Net carrying amount			61,736
Equity
Additional paid-in capital			68,478
Accumulated deficit			$ 6,742

Cash, Cash Equivalents, and I_3

Cash, Cash Equivalents, and Investments - Components of Cash and Cash Equivalents and Investments (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Cash and cash equivalents
Cash	$ 326,999	$ 184,308
Money market funds	27,526	139,870
U.S. Treasury securities	0	14,988
Total cash and cash equivalents	354,525	339,166
Debt Securities, Available-for-sale [Line Items]
Total available-for-sale investments	192,296	221,112
U.S. Treasury securities
Debt Securities, Available-for-sale [Line Items]
Total available-for-sale investments	50,390	45,026
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Total available-for-sale investments	24,635	34,598
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Total available-for-sale investments	$ 117,271	$ 141,488

Cash, Cash Equivalents, and I_4

Cash, Cash Equivalents, and Investments - Carrying Value of Investments (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Cost Basis	$ 192,265	$ 220,769
Unrealized Gain (Loss), Net	31	343
Recorded Basis	192,296	221,112
U.S. Treasury securities
Debt Securities, Available-for-sale [Line Items]
Cost Basis	50,392	45,023
Unrealized Gain (Loss), Net	(2)	3
Recorded Basis	50,390	45,026
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Cost Basis	24,632	34,607
Unrealized Gain (Loss), Net	3	(9)
Recorded Basis	24,635	34,598
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Cost Basis	117,241	141,139
Unrealized Gain (Loss), Net	30	349
Recorded Basis	$ 117,271	$ 141,488

Cash, Cash Equivalents, and I_5

Cash, Cash Equivalents, and Investments - Contractual Maturity (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Cost Basis
Due within one year	$ 149,399	$ 171,498
Due between one to five years	42,866	49,271
Cost Basis	192,265	220,769
Recorded Basis
Due within one year	149,458	171,837
Due between one to five years	42,838	49,275
Recorded Basis	$ 192,296	$ 221,112

Cash, Cash Equivalents, and I_6

Cash, Cash Equivalents, and Investments - Additional Information (Details)	6 Months Ended
	Jul. 31, 2021USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Impairment loss recorded	$ 0

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Recurring - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	$ 27,526	$ 154,858
Included in investments	192,296	221,112
Total	219,822	375,970
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	27,526	154,858
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	192,296	221,112
Fair value of convertible senior notes	364,200
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	0	0
U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	50,390	60,014
U.S. Treasury securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	0	14,988
U.S. Treasury securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	50,390	45,026
U.S. Treasury securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	0	0
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	24,635	34,598
Commercial paper | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	0	0
Commercial paper | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	24,635	34,598
Commercial paper | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	0	0
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	117,271	141,488
Corporate debt securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	0	0
Corporate debt securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	117,271	141,488
Corporate debt securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Included in investments	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	27,526	139,870
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	27,526	139,870
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	0	0
Money market funds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	$ 0	$ 0

Goodwill and Acquired Intangi_3

Goodwill and Acquired Intangible Assets - Schedule of Other Intangible Assets Subject to Amortization (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2021USD ($)
Finite-Lived Intangible Assets [Line Items]
Cost	$ 27,800
Accumulated Amortization	(2,917)
Net	24,883
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Cost	21,800
Accumulated Amortization	(1,817)
Net	$ 19,983
Weighted Average Remaining Useful Life	9 years 2 months 12 days
Developed technology
Finite-Lived Intangible Assets [Line Items]
Cost	$ 5,600
Accumulated Amortization	(933)
Net	$ 4,667
Weighted Average Remaining Useful Life	4 years 2 months 12 days
Trademarks
Finite-Lived Intangible Assets [Line Items]
Cost	$ 400
Accumulated Amortization	(167)
Net	$ 233
Weighted Average Remaining Useful Life	1 year 2 months 12 days

Goodwill and Acquired Intangi_4

Goodwill and Acquired Intangible Assets - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in goodwill			$ 0
Amortization expense related to intangible assets	$ 900,000	$ 0	$ 1,800,000	$ 0

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020	Jan. 31, 2021
Property, Plant and Equipment [Line Items]
Gross property and equipment	$ 27,405		$ 27,405		$ 23,701
Accumulated depreciation and amortization	(13,289)		(13,289)		(11,062)
Property and equipment, net	14,116		14,116		12,639
Depreciation and amortization	1,100	$ 1,000	2,100	$ 1,900
Leasehold improvements
Property, Plant and Equipment [Line Items]
Gross property and equipment	12,957		12,957		12,767
Computers and equipment
Property, Plant and Equipment [Line Items]
Gross property and equipment	7,510		7,510		6,562
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Gross property and equipment	3,002		3,002		3,017
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Gross property and equipment	3,936		3,936		1,355
Construction-in-progress
Property, Plant and Equipment [Line Items]
Gross property and equipment	$ 700		$ 700		$ 500

Deferred Contract Costs (Detail

Deferred Contract Costs (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020	Jan. 31, 2021
Revenue from Contract with Customer [Abstract]
Deferred contract costs	$ 34,300,000		$ 34,300,000		$ 31,600,000
Amortization of deferred contract costs	$ 3,600,000	$ 2,600,000	6,812,000	$ 5,064,000
Impairment loss in relation to costs capitalized			$ 0	$ 0

Leases - Information About Leas

Leases - Information About Lease on Condensed Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Assets
Lease right-of-use assets	$ 22,482	$ 24,691
Liabilities
Lease liabilities	5,469	5,262
Lease liabilities, non-current	$ 23,831	$ 26,542

Leases - Additional Information

Leases - Additional Information (Details)	Jul. 31, 2021
Leases [Abstract]
Weighted average remaining lease term (in years)	5 years 3 months 18 days
Weighted average discount rate	3.70%

Leases - Information About Le_2

Leases - Information About Leases on Condensed Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Leases [Abstract]
Operating lease expense	$ 1,403	$ 1,445	$ 2,772	$ 2,887
Short-term lease expense	79	261	169	560
Variable lease expense	$ 202	$ 361	$ 315	$ 663

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Leases [Abstract]
Cash paid for amounts included in the measurement of lease liabilities	$ 1,571	$ 1,149	$ 3,143	$ 2,287

Debt and Financing Arrangemen_3

Debt and Financing Arrangements - Additional Information (Details) $ / shares in Units, shares in Millions	Jun. 25, 2020USD ($)day$ / sharesshares	Jul. 31, 2021USD ($)	Jul. 31, 2020USD ($)	Jan. 31, 2021USD ($)
Debt Instrument [Line Items]
Conversion rate	0.0249507
Net cost incurred to purchase capped calls		$ 0	$ 35,708,000
Convertible Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount of debt issued	$ 287,500,000	$ 287,500,000
Net proceeds from debt offering, after deducting initial purchaser discounts and debt issuance costs paid or payable	$ 278,200,000
Stated interest rate	1.25%	1.25%
Initial conversion price (in dollars per share) | $ / shares	$ 40.08
Event of default, option to accelerate amounts due, minimum percentage of aggregate principal amount of outstanding debt	25.00%
Carrying amount of equity component representing conversion option	$ 70,800,000	$ 0		$ 70,768,000
Effective interest rate	7.88%	1.93%
Issuance costs attributable to company				9,300,000
Issuance costs attributable to liability component				7,000,000
Less: issuance costs		$ 0		2,290,000
Long-term debt		280,162,000		217,528,000
Unamortized issuance costs		$ 7,338,000		$ 6,308,000
Net cost incurred to purchase capped calls	$ 35,700,000
Convertible Senior Notes | Capped Calls
Debt Instrument [Line Items]
Initial strike price (in dollars per share) | $ / shares	$ 40.08
Cap price (in dollars per share) | $ / shares	$ 61.66
Number of shares of common stock covered by capped calls (in shares) | shares	7.2
Automatic exercise period for capped calls, trading days | day	40
Convertible Senior Notes | Debt Conversion Terms, One
Debt Instrument [Line Items]
Threshold trading days | day	20
Threshold consecutive trading days | day	30
Threshold percentage of stock price trigger	130.00%
Convertible Senior Notes | Debt Conversion Terms, Two
Debt Instrument [Line Items]
Threshold trading days | day	5
Threshold consecutive trading days | day	10
Threshold percentage of product of last reported sales price of common stock and conversion rate on each such trading day	98.00%
Convertible Senior Notes | Discount Rate
Debt Instrument [Line Items]
Liability component calculation, measurement input	0.0730
Convertible Senior Notes | On or after July 6, 2023
Debt Instrument [Line Items]
Threshold trading days | day	20
Threshold consecutive trading days | day	30
Threshold percentage of stock price trigger	130.00%
Redemption, threshold trading days immediately preceding maturity date | day	41
Redemption price, percentage of principal amount to be redeemed	100.00%
Convertible Senior Notes | Fundamental Change
Debt Instrument [Line Items]
Redemption price, percentage of principal amount to be redeemed	100.00%

Debt and Financing Arrangemen_4

Debt and Financing Arrangements - Net Carrying Amount (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Feb. 01, 2021	Jan. 31, 2021	Jun. 25, 2020
Liability Component:
Principal		$ 287,500
Convertible Senior Notes
Liability Component:
Principal	$ 287,500		$ 287,500
Less: unamortized debt discount	0		(63,664)
Less: unamortized issuance costs	(7,338)		(6,308)
Net carrying amount	280,162		217,528
Proceeds allocated to the conversion options (debt discount)	0		70,768	$ 70,800
Less: issuance costs	0		2,290
Carrying amount of the equity component	0		68,478
Equity
Proceeds allocated to the conversion options (debt discount)	0		70,768	$ 70,800
Less: issuance costs	0		(2,290)
Carrying amount of the equity component	$ 0		$ 68,478

Debt and Financing Arrangemen_5

Debt and Financing Arrangements - Interest Expense (Details) - Convertible Senior Notes - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Debt Instrument [Line Items]
Contractual interest expense	$ 918	$ 349	$ 1,797	$ 349
Amortization of debt discount	0	1,145	0	1,145
Amortization of debt issuance costs	460	114	898	114
Total interest expense related to the Notes	$ 1,378	$ 1,608	$ 2,695	$ 1,608

Deferred Revenue and Performa_3

Deferred Revenue and Performance Obligations - Deferred Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Increase (Decrease) In Contract with Customer, Liability [Roll Forward]
Deferred revenue, beginning of period	$ 126,056	$ 96,446	$ 129,972	$ 92,569
Billings	75,482	55,448	135,157	109,111
Revenue recognized	(67,536)	(50,714)	(131,127)	(100,500)
Deferred revenue, end of period	$ 134,002	$ 101,180	$ 134,002	$ 101,180

Deferred Revenue and Performa_4

Deferred Revenue and Performance Obligations - Additional Information (Details) $ in Millions	Jul. 31, 2021USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Future estimated revenue related to performance obligations	$ 118.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, period	24 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, period

Common Stock and Stockholders_3

Common Stock and Stockholders' Equity - Additional Information (Details) $ / shares in Units, $ in Thousands	Apr. 11, 2019purchase_period	Jul. 31, 2021USD ($)$ / sharesshares	Jul. 31, 2020USD ($)$ / sharesshares	Jul. 31, 2021USD ($)equityIncentivePlan$ / sharesshares	Jul. 31, 2020USD ($)$ / sharesshares	Jan. 31, 2021shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plans | equityIncentivePlan				2
Number of shares authorized for grant (in shares)		22,964,193		22,964,193		18,059,506
Number of shares available for grant (in shares)		15,693,636		15,693,636		13,060,282
Weighted average grant date fair value of stock options (in dollars per share) | $ / shares		$ 19.08	$ 12.59	$ 18.23	$ 8.96
Aggregate intrinsic value of stock options exercised | $		$ 25,600	$ 11,600	$ 46,100	$ 23,000
Unrecognized compensation cost related to unvested stock options | $		23,500		23,500
Stock-based compensation expense | $		16,476	9,968	$ 30,088	18,276
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to unvested awards, period for recognition				2 years 3 months 18 days
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to unvested awards, period for recognition				3 years 3 months 18 days
Unrecognized compensation cost related to unvested RSUs | $		145,200		$ 145,200
Awards granted (in shares)				2,127,307
Weight-average grant date fair value (in dollars per share) | $ / shares				$ 41.31
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to unvested awards, period for recognition				1 year 6 months
Unrecognized compensation cost related to unvested RSUs | $		$ 3,400		$ 3,400
Awards granted (in shares)				127,309
Weight-average grant date fair value (in dollars per share) | $ / shares				$ 41.17
Vesting period				3 years
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)		2,721,649		2,721,649
Offering period	24 months
Number of purchase periods within each offering period | purchase_period	4
Purchase period	6 months
Purchase price as a percentage of fair market value of stock on the offering date or the purchase date	85.00%
Stock-based compensation expense | $		$ 1,300	1,200	$ 3,100	2,800
Amount withheld on behalf of employees for future purchase | $		$ 2,000	$ 1,600	$ 5,000	$ 3,500
Shares purchased (in shares)			181,253		181,253
Purchase price (in dollars per share) | $ / shares			$ 19.63		$ 19.63
ESPP | Award One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares purchased (in shares)			171,796		171,796
Purchase price (in dollars per share) | $ / shares		$ 19.63		$ 19.63
ESPP | Award Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares purchased (in shares)			20,269		20,269
Purchase price (in dollars per share) | $ / shares		23.03		23.03
ESPP | Award Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares purchased (in shares)			30,409		30,409
Purchase price (in dollars per share) | $ / shares		$ 34.54		$ 34.54

Common Stock and Stockholders_4

Common Stock and Stockholders' Equity - Shares Available for Issuance (Details) - shares	Jul. 31, 2021	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)	15,693,636	13,060,282
Total common stock reserved at period end (in shares)	33,380,865
Stock options, RSUs and PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding stock options and unvested RSUs outstanding (in shares)	14,965,580
Number of shares available for grant (in shares)	15,693,636
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)	2,721,649

Common Stock and Stockholders_5

Common Stock and Stockholders' Equity - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2021	Jan. 31, 2021
Number of Shares
Outstanding, beginning balance (in shares)	11,177,838
Granted (in shares)	48,866
Exercised (in shares)	(1,286,266)
Canceled (in shares)	(283,443)
Outstanding, ending balance (in shares)	9,656,995	11,177,838
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 8.25
Granted (in dollars per share)	41.52
Exercised (in dollars per share)	6.36
Canceled (in dollars per share)	16.61
Outstanding, ending balance (in dollars per share)	$ 8.43	$ 8.25
Weighted Average Remaining Contractual Term
Outstanding	6 years 6 months	6 years 10 months 24 days
Aggregate Intrinsic Value
Outstanding	$ 310,586	$ 452,452
Vested
Number of shares (in shares)	7,153,532
Weighted average exercise price (in dollars per share)	$ 6.23
Weighted average remaining contractual term (in years)	6 years 1 month 6 days
Aggregate Intrinsic Value	$ 245,762

Common Stock and Stockholders_6

Common Stock and Stockholders' Equity - Assumptions Used to Calculate Fair Value of Employee Stock Option Grants Made (Details)	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield			0.00%
Employee | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	0.00%	0.00%	0.00%	0.00%
Expected volatility, minimum			43.80%	43.30%
Expected volatility, maximum	46.50%	43.90%	46.50%	43.90%
Expected term (years)	6 years 1 month 6 days	6 years 1 month 6 days	6 years 1 month 6 days	6 years 1 month 6 days
Risk-free interest rate	1.04%	0.41%
Risk-free interest rate, minimum			1.04%	0.41%
Risk-free interest rate, maximum			1.16%	0.47%

Common Stock and Stockholders_7

Common Stock and Stockholders' Equity - Restricted Stock Units Activity (Details) - RSUs	6 Months Ended
	Jul. 31, 2021$ / sharesshares
Number of RSUs
Outstanding, beginning balance (in shares) | shares	3,971,128
Granted (in shares) | shares	2,127,307
Vested, net of shares withheld for employee payroll taxes (in shares) | shares	(407,887)
Canceled (in shares) | shares	(636,581)
Outstanding, ending balance (in shares) | shares	5,053,967
Weighted Average Grant Date Fair Value Per Share
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 23.60
Granted (in dollars per share) | $ / shares	41.31
Vested, net of shares withheld for employee payroll taxes (in dollars per share) | $ / shares	23.84
Canceled (in dollars per share) | $ / shares	26.43
Outstanding, ending balance (in dollars per share) | $ / shares	$ 30.68

Common Stock and Stockholders_8

Common Stock and Stockholders' Equity - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 16,476	$ 9,968	$ 30,088	$ 18,276
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	1,023	263	1,699	607
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	5,607	2,469	10,047	4,652
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	4,401	2,870	8,355	5,155
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 5,445	$ 4,366	$ 9,987	$ 7,862

Net Loss Per Share - Calculatio

Net Loss Per Share - Calculation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Numerator:
Net loss	$ (29,661)	$ (14,688)	$ (52,219)	$ (26,147)
Denominator:
Weighted average shares used in calculating net loss per share, diluted (in shares)	83,895	78,775	83,413	78,278
Weighted Average Number of Shares Outstanding, Basic	83,895	78,775	83,413	78,278
Net loss per share, basic (in dollars per share)	$ (0.35)	$ (0.19)	$ (0.63)	$ (0.33)
Net loss per share, diluted (in dollars per share)	$ (0.35)	$ (0.19)	$ (0.63)	$ (0.33)

Net Loss Per Share - Anti-dilut

Net Loss Per Share - Anti-dilutive Securities (Details) - shares shares in Thousands	6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	22,274	23,677
Shares subject to outstanding common stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	14,838	16,298
Convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	7,173	7,173
Restricted stock awards purchased with promissory notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	142
Restricted stock issued to Rundeck key personnel
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	191	0
Shares issuable pursuant to the 2019 Employee Stock Purchase Plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	72	64

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Income Tax Disclosure [Abstract]
Income tax expense	$ 23	$ 248	$ 228	$ 479

Geographic Information - Revenu

Geographic Information - Revenue by Location (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 67,536	$ 50,714	$ 131,127	$ 100,500
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	51,019	38,997	98,761	77,269
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 16,517	$ 11,717	$ 32,366	$ 23,231

Geographic Information - Additi

Geographic Information - Additional Information (Details) - Long-Lived Assets - Geographic Concentration Risk	6 Months Ended	12 Months Ended
	Jul. 31, 2021	Jan. 31, 2021
United States
Concentration Risk [Line Items]
Concentration risk, percentage	85.00%	87.00%
Canada
Concentration Risk [Line Items]
Concentration risk, percentage	15.00%	13.00%